Haematology Oncology
EUTOS Score for Chronic Myelogenous Leukaemia
Predicts achievement of complete cytogenetic response (CCyR) at 18 months in CML treated with imatinib.
References
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Drugs
- Omalizumab (Dermatology — Chronic Urticaria) · Anti-IgE Monoclonal Antibody
- Fentanyl Transdermal Patch (Elderly Chronic Pain) · Opioid Analgesic — Transdermal Patch
- Morphine Slow-Release (Elderly Chronic Pain) · Opioid Analgesic — Modified-Release Oral
- Imatinib · Tyrosine kinase inhibitor (BCR-ABL)
- Methyldopa (Chronic Hypertension in Pregnancy) · Centrally Acting Antihypertensive
- Propranolol (Burns — Hypermetabolic Response) · Beta-Blocker — Burns Hypermetabolism
Pathways
- Major Haemorrhage / Massive Transfusion · BCSH; RCOA; RCEM; RCS — BCSH Guidelines
- Anaemia Investigation · BSH / NICE
- Splenomegaly Workup · BSH; BMJ Best Practice
- Deep Vein Thrombosis Diagnosis and Treatment · NICE CG144 / NICE NG158
- Sickle Cell Crisis · BSH 2021 / BCSH
- Neutropenic Sepsis · NICE CG151 2012 / ESMO
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.